XWELL (XWEL) AI Stock Analysis

• Market Cap: $5.63M
• Dividend Yield: N/A
• Average Volume (3M): 29.75K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.77
• Revenue Growth: -6.93%
• EPS Growth: 22.70%
• Country: US
• Employees: 246
• Sector: Healthcare
• Sector Strength: 45
• Industry: Personal Products & Services
• EPS (TTM): -0.56
• Shares Outstanding: 5,756,703
• 10 Day Avg. Volume: 28,615
• 30 Day Avg. Volume: 29,752
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 2.87
• Enterprise Value/Revenue: 0.53
• Enterprise Value/Gross Profit: 2.57
• Enterprise Value/Ebitda: -1.18
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 41 Neutral
• Price Target: $1.00 ▲(0.00% Upside)

XWELL's overall stock score is primarily impacted by its poor financial performance, characterized by negative equity and cash flow issues. Technical analysis suggests a bearish trend, further weighing on the score. The negative P/E ratio and lack of dividend yield contribute to a challenging valuation, making the stock less attractive to investors.

XWELL Business Overview & Revenue Model

Company Description

XWELL (XWEL) is a wellness-focused company that operates primarily in the health and wellness sector, providing innovative solutions and services designed to enhance the well-being of its customers. The company specializes in health-related products and services, including wellness facilities, health assessments, and personalized health programs aimed at improving physical and mental health outcomes.

How the Company Makes Money

XWELL generates revenue through multiple streams, including service fees from wellness assessments, memberships for access to health facilities, and sales of health-related products. The company also partners with corporate clients to provide wellness programs for their employees, creating a steady revenue source from corporate contracts. Additionally, XWELL may benefit from retail partnerships and collaborations that enhance its market reach, contributing to its overall earnings.

XWELL Financial Statement Overview

Summary

XWELL is facing significant financial challenges, with deteriorating revenue and profitability metrics. The balance sheet shows weakened financial health with negative equity, and cash flow issues persist, reflecting operational inefficiencies and liquidity concerns. The company is under financial distress, requiring strategic adjustments to improve its financial position.

Income Statement

The company's revenue has decreased significantly over the years, with a notable decline from 2021 to 2023. Gross profit margin improved slightly in 2023 compared to 2022, but remains weak at 26.3%. Net profit margin is negative, indicating consistent losses. EBIT and EBITDA margins are also negative, reflecting operational challenges despite some improvement in EBIT in 2024.

Balance Sheet

The company has a negative stockholders' equity in 2024, indicating financial distress. The debt-to-equity ratio is not meaningful due to negative equity. The equity ratio is also negative, signaling potential solvency issues. Total assets have decreased significantly, impacting the company's financial stability.

Cash Flow

Operating cash flow is negative, indicating cash outflows from operations. Free cash flow is also negative, reflecting ongoing financial strain. Cash flow from financing activities has been inconsistent, with a significant drop in 2024. The operating cash flow to net income ratio suggests poor cash generation relative to net income.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	30.60M	33.90M	30.11M	55.94M	73.73M	8.38M
Gross Profit	6.27M	8.92M	3.68M	12.05M	32.43M	-3.60M
EBITDA	-13.69M	-13.99M	-15.75M	-19.12M	7.87M	-19.54M
Net Income	-19.33M	-16.85M	-27.74M	-32.63M	3.35M	-92.23M
Balance Sheet
Total Assets	22.45M	25.35M	38.99M	70.43M	127.27M	103.13M
Cash, Cash Equivalents and Short-Term Investments	8.15M	11.80M	23.05M	42.19M	105.51M	89.80M
Total Debt	9.98M	10.77M	11.09M	14.11M	13.82M	15.38M
Total Liabilities	18.32M	17.61M	18.02M	22.48M	27.33M	22.76M
Stockholders Equity	-4.77M	-788.00K	13.00M	39.93M	92.73M	77.81M
Cash Flow
Free Cash Flow	-15.90M	-12.80M	-18.45M	-31.02M	6.97M	-29.36M
Operating Cash Flow	-13.44M	-11.01M	-16.07M	-24.19M	15.64M	-25.01M
Investing Cash Flow	7.80M	5.89M	5.65M	-34.84M	-6.24M	-4.35M
Financing Cash Flow	5.00M	1.36M	8.00K	-27.38M	6.35M	117.22M

XWELL Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For XWEL, the sentiment is Negative. The current price of 1 is below the 20-day moving average (MA) of 1.00, below the 50-day MA of 1.07, and below the 200-day MA of 1.03, indicating a bearish trend. The MACD of -0.02 indicates Negative momentum. The RSI at 42.32 is Neutral, neither overbought nor oversold. The STOCH value of 13.04 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for XWEL.

XWELL Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
RGS	72 Outperform	$74.22M	0.70	96.56%	―	3.52%	26.12%
MRM	64 Neutral	$19.20M	13.81	48.22%	―	12.93%	66.81%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
MED	46 Neutral	$139.81M	39.05	1.73%	―	-37.62%	-87.69%
TRNR	41 Neutral	$6.18M	―	-259.91%	―	373.32%	98.46%
XWEL	41 Neutral	$5.63M	―	-1069.01%	―	-6.93%	22.70%

XWELL Corporate Events

XWELL Cancels 2025 Annual Stockholders Meeting

On August 8, 2025, XWELL, Inc. announced the cancellation of its 2025 annual meeting of stockholders, initially scheduled to reconvene on October 10, 2025. The company plans to reschedule the meeting and will issue a new proxy statement, reflecting its ongoing commitment to transparent communication with its stakeholders.

The most recent analyst rating on (XWEL) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on XWELL stock, see the XWEL Stock Forecast page.

XWELL Adjourns Annual Meeting for Shareholder Voting

On September 16, 2025, XWELL, Inc. adjourned its 2025 Annual Meeting of Stockholders to provide additional time for shareholders to consider and vote on the company’s proposals. The meeting will reconvene virtually on October 10, 2025, with the proxy deadline set for October 9, 2025. Shareholders who have already voted do not need to take further action unless they wish to change their vote. The company has filed a Definitive Proxy Statement with the SEC, which contains important information about the meeting and the company.

The most recent analyst rating on (XWEL) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on XWELL stock, see the XWEL Stock Forecast page.

XWELL Reports Q2 2025 Results and Strategic Expansions

XWELL, Inc., a global wellness company, offers science-proven wellness solutions across travel, retail, and clinical settings through its diverse portfolio of brands. In its second quarter of 2025, XWELL reported revenues of $7.7 million, reflecting a sequential increase from the previous quarter but a decrease from the same period last year. The company highlighted a decrease in cost of sales and administrative expenses, alongside strategic expansions and partnerships. Key developments include being named the official wellness spa for the Orlando Magic and expanding its Priority Pass partnership. XWELL also opened a new wellness center in Clearwater, Florida, and is planning further expansions in high-demand cities. Despite an operating loss of $2.7 million, the company remains focused on executing its growth strategy and enhancing customer engagement. Looking ahead, XWELL is optimistic about its strategic initiatives and continued growth in the wellness market.

XWELL Regains Nasdaq Compliance After Bid Price Recovery

On August 7, 2025, XWELL, Inc. announced that it has regained compliance with the Nasdaq Listing Rule 5550(a)(2) after its common shares maintained a closing bid price of at least $1.00 for 16 consecutive business days, from July 16, 2025, to August 6, 2025. This follows a previous notification from Nasdaq on May 13, 2025, regarding the company’s failure to meet the minimum bid price requirement, which has now been resolved.

XWELL Amends Bylaws to Alter Voting Requirements

On July 24, 2025, XWELL, Inc. amended its bylaws to change the voting requirements for stockholder decisions. The amendment lowers the required stockholder vote for matters other than director elections to a majority of votes cast, excluding abstentions and broker non-votes, potentially impacting the company’s decision-making process and shareholder influence.